The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N''-[2-(1H-benzimidazol-2-ylthio)-2,3-dihydro-1H-inden-1-ylidene]carbonohydrazonic diamide dihydrochloride ID: ALA3215581
PubChem CID: 44224560
Max Phase: Preclinical
Molecular Formula: C17H18Cl2N6S
Molecular Weight: 336.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cl.Cl.NC(N)=N/N=C1\c2ccccc2CC1Sc1nc2ccccc2[nH]1
Standard InChI: InChI=1S/C17H16N6S.2ClH/c18-16(19)23-22-15-11-6-2-1-5-10(11)9-14(15)24-17-20-12-7-3-4-8-13(12)21-17;;/h1-8,14H,9H2,(H,20,21)(H4,18,19,23);2*1H/b22-15+;;
Standard InChI Key: SSEKUPWHYBWPJA-IFGMWRHRSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
10.3731 0.2552 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.5164 5.9854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8290 5.2698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8731 3.7507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2157 5.1993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2685 3.6962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5811 2.9807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3007 1.5139 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8208 1.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1876 2.6658 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0872 0.0382 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1855 -2.6254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1889 -3.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6614 -5.1720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8646 -6.0692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8368 -5.4139 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8731 0.2552 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
3 4 1 0
13 16 1 0
15 14 1 0
14 12 1 0
4 7 2 0
2 3 2 0
15 16 2 0
6 5 2 0
16 17 1 0
7 8 1 0
17 18 2 0
8 9 1 0
18 19 1 0
9 10 2 0
19 20 2 0
20 15 1 0
10 6 1 0
14 21 2 0
5 2 1 0
21 22 1 0
9 11 1 0
22 23 2 0
6 7 1 0
23 24 1 0
11 12 1 0
23 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 336.42Molecular Weight (Monoisotopic): 336.1157AlogP: 2.26#Rotatable Bonds: 3Polar Surface Area: 105.44Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.39CX Basic pKa: 7.18CX LogP: 2.56CX LogD: 2.36Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.39Np Likeness Score: -0.80
References 1. Zhang R, Dong J, Xu YG, Hua WY, Wen N, You QD.. (2009) Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives., 44 (9): [PMID:19482383 ] [10.1016/j.ejmech.2009.04.036 ]